- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0091684

About Rebase Lifescience Private Limited
Data last updated:
Rebase Lifescience Private Limited is a private limited company based in Lalpur, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2019PTC106089. Its GSTIN is 24AAJCR3607A1ZV (Gujarat).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹10 Cr. It is led by directors including Miteshkumar Gordhanbhai Patel and Yogesh Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.11 & 12 Block No.6 Nr. Amrut Dairy, Lalpur, Gujarat, India – 382430.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.59 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹1.28 Cr (net margin -14.9%) and EBITDA of ₹45.29 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 182% over three years.
The company has about 32 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Rebase Lifescience. As per MCA filings, the company has open charges of ₹10.5 Cr on record. The company has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in September 2022. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Srikar Chem & Pharma India Private Limited with revenue of ₹8.6 Cr.
Rebase Lifescience Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0091684). For more details, the company can be reached via its website rebaselifescience.com.
Company details
Recognitions & Rankings of Rebase Lifescience
Contact details
Rebase Lifescience Private Limited's registered office is in Lalpur, Gujarat. Its website is rebaselifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.11 & 12 Block No.6 Nr. Amrut Dairy, Lalpur, Gujarat, India – 382430
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rebase Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Rebase Lifescience operates one associated brand: Rebase Lifescience. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing of oral dosage forms in Ahmedabad, India. | rebaselifescience.com |
Business activity
The main business activity of Rebase Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rebase Lifescience Private Limited, buy the company report.
Financials of Rebase Lifescience Private Limited
FY 2024 filings availableRebase Lifescience Private Limited reported revenue of ₹8.59 Cr (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 182% over three years, including 8% growth in the latest year. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45.29 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.28 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | -14.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rebase Lifescience Private Limited, buy the company report.
Board of directors of Rebase Lifescience Private Limited
Rebase Lifescience has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Miteshkumar Gordhanbhai Patel | Director | 15 Jan 2019 | 7 Years 10 Months | Current |
| Yogesh Shah | Director | 31 May 2024 | 2 Years 5 Months | Current |
| Minesh Manharlal Suthar | Director | 24 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Rebase Lifescience Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Srikar Chem & Pharma India Private Limited | ₹8.6 Cr (FY 2024) | -11.0% | Hyderabad, Telangana, India | |||
| Zahidi Pharmaceuticals Private Limited | ₹8.6 Cr (FY 2025) | 2.0% | Umbergaon, Gujarat, India | |||
| Kaizen Research Labs India Private Limited | ₹8.6 Cr (FY 2025) | -17.0% | Chennai, Tamil Nadu, India | |||
| Rebase Lifescience Private Limitedthis company | ₹8.59 Cr (FY 2025) | -₹1.28 Cr | -14.9% | 8.0% | 32 | Lalpur, Gujarat, India |
| Qpharm Health Care Limited | ₹8.59 Cr (FY 2024) | 40.0% | Jaipur, Rajasthan, India | |||
| Rexcin Pharmaceuticals Private Limited | ₹8.57 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Lutim Pharma Private Limited | ₹8.57 Cr (FY 2024) | 6.0% | Dehradun, Uttarakhand, India |
To see the full peer comparison of Rebase Lifescience Private Limited, buy the company report.
Auditor
Rebase Lifescience Private Limited is audited by B S Pandya & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S Pandya & Associates | FY 2024 | 142825W |
Shareholding
The shareholding of Rebase Lifescience Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rebase Lifescience Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jan 2021 | 100415278 | State Bank of India | ₹5.25 Cr | Open | |
| 22 Jan 2021 | 100415286 | State Bank of India | ₹5.25 Cr | Open |
Total charge records: 2 View all charges
Deals & funding
Rebase Lifescience Private Limited has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in September 2022.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2021 | Rights issue | ₹4.14 Cr | Investors: 4 individuals Seller: an individual |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2019 | Rights issue | ₹1.49 Cr | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Rebase Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rebase Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rebase Lifescience Private Limited has a workforce of 32 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 32 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Rebase Lifescience Private Limited, buy the company report.
GST
Rebase Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCR3607A1ZV | Gujarat | Active | 04 Feb 2019 |
To see the full GST registrations and return filing status of Rebase Lifescience Private Limited, buy the company report.
Recent activity
Rebase Lifescience Private Limited has 7 board changes on record since 2019: 3 appointments and 4 cessations. The latest: Yogesh Shah ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Rebase Lifescience is an active private limited company based in Lalpur, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 January 2019 (7+ years old) and is registered under CIN U24290GJ2019PTC106089.
Rebase Lifescience has 3 current directors:
- Miteshkumar Gordhanbhai Patel - Director
- Yogesh Shah - Director
- Minesh Manharlal Suthar - Director
The latest financial statements of Rebase Lifescience on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Rebase Lifescience is 24AAJCR3607A1ZV, registered in Gujarat.
The CIN (Corporate Identification Number) of Rebase Lifescience is U24290GJ2019PTC106089. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rebase Lifescience was incorporated on 15 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Rebase Lifescience has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in September 2022.
The peers of Rebase Lifescience by revenue are Srikar Chem & Pharma India Private Limited, Zahidi Pharmaceuticals Private Limited, Kaizen Research Labs India Private Limited, Qpharm Health Care Limited, Rexcin Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Yogesh Shah ceased to be Additional Director on 29 Sep 2024. Yogesh Shah was appointed as Director on 31 May 2024. Minesh Manharlal Suthar ceased to be Additional Director on 15 Oct 2021. Rebase Lifescience has 7 board changes on record in total.
Yes, Rebase Lifescience is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0091684).
Rebase Lifescience can be reached through the website rebaselifescience.com. Its registered office is in Lalpur, Gujarat, India.

